Results 211 to 220 of about 368,530 (304)

LRRK2 as a Potential Disease‐Modifying Target in Sporadic Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract A growing understanding of the role that leucine‐rich repeat kinase 2 (LRRK2) plays in Parkinson's disease (PD) supports continued focus on this enzyme as a therapeutic target for PD. Accumulating evidence suggests that there are phenotypic, neuropathologic, and biological similarities between sporadic PD (sPD) and familial forms in which ...
Anthony E. Lang   +12 more
wiley   +1 more source

Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE‐PD)

open access: yesMovement Disorders, EarlyView.
Abstract Background The optimal design for care delivery in Parkinson's disease (PD) that addresses changing needs of the lived experience is unclear. There is a critical need for care models to be implemented and transferable across diverse healthcare systems with agility.
Deepa Dash   +34 more
wiley   +1 more source

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa‐Therapy in Parkinson's Disease: A Randomized, Placebo‐Controlled Study (PREMANDYSK)

open access: yesMovement Disorders, EarlyView.
Abstract Objective Investigate the efficacy of immediate‐release (IR) amantadine in reducing the risk of peak‐dose dyskinesia in early Parkinson's disease (PD) as add‐on to levodopa. Background While the use of amantadine to manage dyskinesia in PD is well supported by controlled clinical trials, data on its efficacy in patients without motor ...
Olivier Rascol   +106 more
wiley   +1 more source

2017 Guidelines for Arterial Hypertension Management in Primary Health Care in Portuguese Language Countries. [PDF]

open access: yesArq Bras Cardiol, 2017
Oliveira GMM   +12 more
europepmc   +1 more source

Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review

open access: yesMovement Disorders, EarlyView.
Abstract Background The first International Parkinson and Movement Disorder Society Evidence‐Based Medicine (MDS‐EBM) review for essential tremor (ET) was published in 2019; since then, the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was adopted by MDS, and new evidence exists.
Deepa Dash   +12 more
wiley   +1 more source

Validation of the French Translation of the Movement Disorder Society Non‐Motor Symptoms Scale (MDS‐NMS) in Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Clément Desjardins   +283 more
wiley   +1 more source

Telemedicine as a Lifeline: Addressing Mental Health Challenges in Pregnancy and Early Motherhood

open access: yesMedicine Advances, EarlyView.
This illustration highlights four key benefits of telemedicine in perinatal mental health: remote psychological care, digital therapies and AI triage, privacy‐preserving access, and support for underserved populations. Together, these tools promote timely, personalized, and equitable care during pregnancy and the early postpartum period.
Tiago Cunha Reis
wiley   +1 more source

Home - About - Disclaimer - Privacy